Skip to content

Clinical trials

Hypertension, Pulmonary trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Czechia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20071
20084
20094
20103
20144
20161
20171
20181
20193
20211
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated9
Recruiting4
Active, not recruiting2
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer11
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Actelion3
Pfizer3
Biogen2
United Therapeutics2
Abbott Medical Devices1
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
AstraZeneca1
General University Hospital, Prague1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary35
Pulmonary Arterial Hypertension13
Cardiovascular Diseases4
Heart Failure4
Lung Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Heart Diseases2
Hypertension2

Trials

Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.